Latest News and Press Releases
Want to stay updated on the latest news?
-
VIRGINIA BEACH, Va., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Armada Hoffler (NYSE: AHH) today announced that it has priced an underwritten public offering of 9,000,000 shares of its common stock for...
-
ROCHESTER, NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- With nearly 11% of the global GDP light-enabled, Syntec Optics Chairman and CEO Al Kapoor is excited to deliver a keynote speech at the Global...
-
CALGARY, Alberta, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Traction Uranium Corp. (CSE: TRAC) (OTC: TRCTF) (FRA: Z1K) (the “Company” or “Traction”) announces, further to its news release of September 5,...
-
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Consolidated Lithium Metals Inc. (TSXV: CLM | OTCQB: JORFF...
-
La société a des racines françaises et des liens significatifs avec la France La société collabore étroitement avec le CEA-Clinatec, institut de recherche biomédicale de renommée mondiale financé par...
-
CHICAGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The National Association of Realtors® today announced a new series of consumer resources designed to help agents who are Realtors® empower home buyers and...
-
Washington, D.C., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Key Highlights Existing-home sales retreated 2.5% in August to a seasonally adjusted annual rate of 3.86 million. Sales slid 4.2% from...
-
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- NOTICE TO THE HOLDERS OF: EUR 200,000,000 EURO FIXED RATE ENHANCED CAPITAL ADVANTAGED PREFERRED SECURITIES ("LP IV ECAPS") ISSUER: LEHMAN BROTHERS...
-
TSX Approves ECN Capital’s Normal Course Issuer Bids for Common Shares and Series C Preferred Shares
TORONTO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ECN Capital Corp. (TSX: ECN, ECN.PR.C) (“ECN Capital” or the “Company”) today announced that the Toronto Stock Exchange (the “TSX”) has approved the...
-
SUNNYVALE, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...